BAO PHARMA
Live / Allowed — Approved for publication (as of 17 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 May 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99815796
- Mark type
- Design + words
- Filed
- 11 May 2026
- Attorney of record
- Alex Patel
Goods and services
- Class 005 — Pharmaceuticals: Medicines for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Pharmaceutical preparations for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Enzymes for medical purposes; Enzyme preparations for medical purposes; Aqueous solutions for medical purposes, namely, for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Biochemical drugs for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Drugs for medical purposes, namely, for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Pharmaceutical preparations and substances for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Injectable solutions for medical purposes, namely, for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Biological preparations for medical purposes, namely, for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility
Owner
- Shanghai Bao Pharmaceuticals Co., Ltd., Shanghai, CN
Prior registrations
Prosecution history
- 17 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Sept 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 16 Sept 2026 — EXAMINER'S AMENDMENT ENTERED
- 16 Sept 2026 — EXAMINERS AMENDMENT E-MAILED
- 16 Sept 2026 — EXAMINERS AMENDMENT -WRITTEN
- 14 Sept 2026 — ASSIGNED TO EXAMINER
- 14 Sept 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 13 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 May 2026 — APPLICATION FILING RECEIPT MAILED
- 11 May 2026 — NEW APPLICATION ENTERED